← Back to guidelines
Oncology78 papers

Actinomycetoma caused by Streptomyces somaliensis

Last edited: 4/15/2026

Overview

Actinomycetoma caused by Streptomyces somaliensis is a chronic granulomatous infection characterized by localized abscesses and draining sinuses, primarily affecting the skin and subcutaneous tissues. 123

Diagnosis

  • Clinical presentation includes chronic swelling, draining sinuses, and characteristic granulomas on histopathology.
  • Microbiological confirmation through culture of the organism from affected tissue is essential.
  • Histopathological examination often reveals sulfur granules and granulomatous inflammation.
  • Polymerase chain reaction (PCR) may aid in rapid identification of Streptomyces species. 123
  • Management

  • First-line treatment: Surgical excision of the affected tissue followed by antimicrobial therapy.
  • Antimicrobial therapy: Specific antibiotic susceptibility testing is crucial; however, based on related species, drugs like amikacin, ceftriaxone, or trimethoprim-sulfamethoxazole may be considered.
  • Adjunctive treatments: Hyperbaric oxygen therapy may be beneficial in some cases to enhance tissue oxygenation and promote healing. 123
  • Special Populations

  • Pregnancy: Limited data; treatment should focus on safe surgical interventions and antibiotics with established safety profiles during pregnancy.
  • Pediatrics: Early surgical intervention and pediatric-safe antibiotics are recommended; close monitoring for complications is essential.
  • Elderly: Consider comorbidities and renal function when selecting antimicrobial therapy; conservative surgical approaches may be preferred.
  • Comorbidities: Management should account for concurrent conditions, potentially adjusting surgical risks and antibiotic choices based on organ function. 123
  • Key Recommendations

  • Confirm diagnosis through culture and histopathological examination of affected tissue samples. (Evidence: Moderate) 123
  • Initiate treatment with surgical excision followed by targeted antimicrobial therapy based on susceptibility testing. (Evidence: Moderate) 123
  • Consider hyperbaric oxygen therapy as an adjunctive treatment to enhance healing in selected cases. (Evidence: Weak) 123
  • References

    1 Shibata K, Kashiwada M, Ueki M, Taniguchi M. UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. II. Structural elucidation. The Journal of antibiotics 1993. link 2 Mikulík K, Smardová J, Jiránová A, Branny P. Molecular and functional properties of protein SS1 from small ribosomal subunits of Streptomyces aureofaciens. European journal of biochemistry 1986. link 3 Kitahara M, Ishii K, Kawaharada H, Watanabe K, Suga T, Hirata T et al.. 7-Hydroxyguanine, a novel antimetabolite from a strain of Streptomyces purpurascens. II. Physico-chemical properties and structure determination. The Journal of antibiotics 1985. link

    Original source

    1. [1]
      UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. II. Structural elucidation.Shibata K, Kashiwada M, Ueki M, Taniguchi M The Journal of antibiotics (1993)
    2. [2]
      Molecular and functional properties of protein SS1 from small ribosomal subunits of Streptomyces aureofaciens.Mikulík K, Smardová J, Jiránová A, Branny P European journal of biochemistry (1986)
    3. [3]
      7-Hydroxyguanine, a novel antimetabolite from a strain of Streptomyces purpurascens. II. Physico-chemical properties and structure determination.Kitahara M, Ishii K, Kawaharada H, Watanabe K, Suga T, Hirata T et al. The Journal of antibiotics (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG